GTG shares soar on back of Applera lawsuit news

By Renate Krelle
Monday, 20 September, 2004

The share price of Genetic Technologies (ASX: GTG) has risen over 50 per cent since the judge in GTG's lawsuit against Applera ruled largely in the company's favour during the Markman hearing last Thursday.

GTG were up from AUD$0.38 last Thursday to AUD$0.59 at time of writing.

In the hearing, the court examined 15 disputed technical terms within GTG's patent claims, ruling in favour of GTG's definition in 13 cases, and adopting a definition consistent with GTG's position for the other two terms.

Related News

RSV immunisation program for babies slashes hospital stays

An Australian-first study has demonstrated the effectiveness of immunisation against respiratory...

A targeted treatment option for psoriasis

New research from MedUni Vienna paves the way for the development of a therapy that not only...

Maternal cannabis use puts kids at risk of behavioural problems

Children exposed to their mother's cannabis use during pregnancy and after birth are three...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd